Company Filing History:
Years Active: 2018-2022
Title: Inventor Spotlight: Marta Vivancos Martinez
Introduction
Marta Vivancos Martinez is a notable inventor based in Sant Boi de Llobregat, Spain. With seven patents to her name, she has made significant contributions to the field of pharmaceuticals. Her innovative work primarily focuses on enhancing the effectiveness of pharmaceutical compositions.
Latest Patents
Marta Vivancos Martinez's most recent patents demonstrate her commitment to improving medical treatments. One of her notable inventions is a pharmaceutical composition comprising Palbociclib. This invention presents a pharmaceutical granulate composition that includes the Palbociclib free base, specifically designed to enhance bioavailability.
Another significant patent relates to a pharmaceutical composition containing amorphous lenalidomide along with an antioxidant. This invention revolves around a composition intended for medical use, particularly for the treatment of multiple myeloma and myelodysplastic syndromes. It not only describes the composition but also elaborates on the process for its manufacture and potential applications as a medicament.
Career Highlights
Marta has been working at Synthon B.V., where she leverages her extensive knowledge and expertise in pharmaceuticals. Her role involves leading innovative projects aimed at developing new drug formulations to improve patient outcomes.
Collaborations
Throughout her career, Marta has collaborated with esteemed colleagues, including Lisardo Alvarez Fernandez and Jose Velada Calzada. These partnerships enhance the dynamic exchange of ideas and foster the creation of groundbreaking patents in the pharmaceutical industry.
Conclusion
Marta Vivancos Martinez exemplifies the spirit of innovation in the pharmaceutical sector. Her seven patents highlight her dedication to developing advanced medical treatments that can significantly impact patients' lives. With ongoing work at Synthon B.V. and collaborations with talented colleagues, her contributions to science and medicine continue to expand.